Nanophytomedicine: Harnessing Nature and Nanotechnology for Neurological and Metabolic Health
Where Nature Meets Nanotechnology: New Book Charts a New Path for Brain and Metabolic Health
Bentham Books announces the release of NanoPhytomedicine: Harnessing Nature and Nanotechnology for Neurological and Metabolic Health , a timely reference exploring the emerging convergence of plant-based medicine and nanoscale delivery systems to tackle some of today's most pressing health challenges.
About the Book
This book combines the healing potential of bioactive compounds derived from plants with advanced nanoscale delivery systems, highlighting the emerging convergence of phytomedicine and nanotechnology in the development of innovative therapeutic strategies for neurological and metabolic disorders.
It presents new approaches for addressing conditions including depression, anxiety, obesity, diabetes and metabolic syndrome. Emphasizing the limitations of conventional therapies, the volume positions nano-enabled phytomedicine as a promising avenue for improving treatment efficacy, bioavailability and patient outcomes. Various nanoscale delivery platforms including liposomes, polymeric nanoparticles and nanostructured lipid carriers are discussed in detail, demonstrating their ability to enhance targeted delivery and minimize adverse effects. Particular attention is given to the complex, bidirectional relationship between mental health and metabolic disorders, highlighting the potential of nano-enhanced natural products as dual-action therapeutic solutions.
Supported by case studies and recent research advances, the book showcases successful applications of nanophytomedicine, including curcumin-loaded nanoparticles for cognitive enhancement and resveratrol-based nanodelivery systems for managing metabolic disorders. By integrating traditional natural medicine with modern nanotechnology, the volume offers valuable insights into the development of safer, more effective and personalized therapeutic approaches.
Key Features
Readership: Researchers, academics, clinicians, pharmaceutical scientists and industry professionals working on or interested in next-generation therapies for neurological and metabolic disorders.
About the Editors
Mandeep Kumar Gupta, Amity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, India.
Rajnish Srivastava, Chitkara University School of Pharmacy, Chitkara University, Baddi, Himachal Pradesh, India.
Pradeep Singh, School of Pharmacy, Chandigarh University Uttar Pradesh, Unnao, Uttar Pradesh, India.
Kanupriya Chauhan, Faculty of Pharmacy, Moradabad Educational Trust Group of Institutions, Moradabad, Uttar Pradesh, India.
Naveen Singh, Chitkara University School of Pharmacy, Chitkara University, Baddi, Himachal Pradesh, India.
Book Link: https://bit.ly/3VOdxjF
DOI: 10.2174/97988988157071260101